ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Darren SIGAL, MD
Scripps Clinic/Scripps MD Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Scripps Clinic Torrey Pines
La Jolla, California, United States
Recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Aug 2019
- Primary completion
- 30 Jun 2021
- Completion
- 30 Jun 2023
- Last update posted
- 26 Mar 2021
- Registered enrollment
- 48
- Registry id
- NCT03897543
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.